Literature DB >> 10811133

A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids.

A K Chakraborty1, S Sodi, M Rachkovsky, N Kolesnikova, J T Platt, J L Bolognia, J M Pawelek.   

Abstract

Cells from a lung metastasis, arising from Cloudman S91 melanoma cells implanted s.c. in the tail of a BALB/c nu/nu mouse, were comprised chiefly of host x tumor hybrids. These lung metastasis cells showed: (a) 30-40% increased DNA content; (b) resistance to 10(-4) M hypoxanthine, 4 x 10(-7) M aminopterin, and 1.6 x 10(-5) M thymidine (HAT) + G418; and (c) the presence in genomic DNA of genes for both wt and albino tyrosinase, reflecting the DBA/2J (Cloudman S91) and BALB/c mouse genotypes, respectively. Individual clones of lung metastasis cells expressed enhanced pigmentation, motility, and responsiveness to MSH/IBMX, a behavior similar to that recently reported for artificially generated melanoma x macrophage fusion hybrids. These similarities suggested that the host fusion partner generating the lung metastasis hybrids might have been a macrophage, although formal proof for this was not possible. The results provide the first direct evidence that host x tumor hybridization could serve as an initiating mechanism for melanoma metastasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811133

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 2.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

3.  Fusion between tumor cells enhances melanoma metastatic potential.

Authors:  Ruifang Mi; Chunxiao Pan; Xiaocui Bian; Liqiang Song; Wenjia Tian; Fang Cao; Juan Yin; Haiyong Peng; Jianhui Ma
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-24       Impact factor: 4.553

4.  Spontaneous formation of tumorigenic hybrids between human omental adipose-derived stromal cells and endometrial cancer cells increased motility and heterogeneity of cancer cells.

Authors:  Mingxia Li; Xiaoping Li; Lijun Zhao; Jingyi Zhou; Yuan Cheng; Bo Xu; Jianliu Wang; Lihui Wei
Journal:  Cell Cycle       Date:  2019-01-22       Impact factor: 4.534

5.  Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells.

Authors:  Thomas Dittmar; Sarah Schwitalla; Jeanette Seidel; Sonja Haverkampf; Georg Reith; Sönke Meyer-Staeckling; Burkhard H Brandt; Bernd Niggemann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2010-10-28       Impact factor: 5.150

6.  Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo.

Authors:  David M Goldenberg; David Zagzag; Kerstin M Heselmeyer-Haddad; Lissa Y Berroa Garcia; Thomas Ried; Meiyu Loo; Chien-Hsing Chang; David V Gold
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

7.  Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.

Authors:  Ivan Shabo; Hans Olsson; Rihab Elkarim; Xiao-Feng Sun; Joar Svanvik
Journal:  Cancer Microenviron       Date:  2014-04-28

Review 8.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 9.  GnT-V, macrophage and cancer metastasis: a common link.

Authors:  A K Chakraborty; J M Pawelek
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 10.  Viewing malignant melanoma cells as macrophage-tumor hybrids.

Authors:  John M Pawelek
Journal:  Cell Adh Migr       Date:  2007-01-15       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.